Abstract Background: Participant discontinuation is a significant challenge in pharmacological trials for trichotillomania (hair-pulling disorder). Attrition in clinical trials reduces…
Abstract Introduction: Aromatase inhibitor (AI) therapy reduces breast cancer recurrence risk. However, some patients stop treatment early because of AI‐associated…
Abstract Atopic dermatitis is a chronic inflammatory skin disease characterized by flare-ups of inflamed, dry, and itchy skin affecting over…
Abstract Introduction: Cannabidiol (CBD) has recently gained attention for its potential therapeutic effects in substance use disorders, including Alcohol Use…
Abstract Introduction: Acute pain levels following orthopaedic injury (eg, fracture) are a predictor of the onset of chronic pain, which…
Abstract Introduction: Chronic pain is common among Veterans, some of whom use cannabis for pain. We conducted a feasibility pilot…
Abstract Introduction: Diabetic peripheral neuropathy (DPN) represents a prevalent neurological complication affecting millions of patients globally. This clinical investigation evaluated…
Abstract Background: Finding new strategies to treat cognitive disorders is a challenging task. Medication must defeat the blood–brain barrier. Cannabidiol…
Abstract Clinical trial participation across disease areas, including Alzheimer’s disease (AD), has been biased towards White participants of European ancestry.…
Abstract Background: Chronic pain affects over 100 million Americans, with a disproportionately high number being Veterans. Chronic pain is often…